Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 4: 6307, 2014 Sep 09.
Article in English | MEDLINE | ID: mdl-25200751

ABSTRACT

Xanthine oxidase (XOD) is an enzyme which plays a central role in purine catabolism by converting hypoxanthine into xanthine and then further into uric acid. Here we report that XOD is activated in THP-1 human myeloid cells in response to pro-inflammatory and growth factor stimulation. This effect occurred following stimulation of THP-1 cells with ligands of plasma membrane associated TLRs 2 and 4, endosomal TLRs 7 and 8 as well as stem cell growth factor (SCF). Hypoxia-inducible factor 1 (HIF-1) and activator protein 1 (AP-1) transcription complexes were found to be responsible for XOD upregulation. Importantly, the mammalian target of rapamycin (mTOR), a major myeloid cell translation regulator, was also found to be essential for XOD activation. Specific inhibition of XOD by allopurinol and sodium tungstate led to an increase in intracellular AMP levels triggering downregulation of mTOR activation by phosphorylation of its T2446 residue. Taken together, our results demonstrate for the first time that XOD is not only activated by pro-inflammatory stimuli or SCF but also plays an important role in maintaining mTOR-dependent translational control during the biological responses of human myeloid cells.


Subject(s)
Inflammation/immunology , Myeloid Cells/physiology , TOR Serine-Threonine Kinases/metabolism , Xanthine Oxidase/metabolism , Allopurinol/pharmacology , Animals , Cell Line, Tumor , Down-Regulation , Enzyme Activation , Humans , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Lipopolysaccharides , Liver/metabolism , MCF-7 Cells , Male , Mice , Peptidoglycan , Phosphatidylinositol 3-Kinases/metabolism , Phosphoinositide-3 Kinase Inhibitors , Phosphorylation , RNA Interference , RNA, Small Interfering , Stem Cell Factor/metabolism , Toll-Like Receptor 2/metabolism , Toll-Like Receptor 4/metabolism , Toll-Like Receptor 7/metabolism , Toll-Like Receptor 8/metabolism , Transcription Factor AP-1/antagonists & inhibitors , Transcription Factor AP-1/metabolism , Tungsten Compounds/pharmacology , Uric Acid/analysis , Xanthine Oxidase/antagonists & inhibitors , Xanthine Oxidase/biosynthesis
2.
Immunol Cell Biol ; 89(2): 268-74, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20661259

ABSTRACT

Toll-like receptors (TLRs) lie in the core of resistance to infectious diseases allowing host immune cells to specifically detect pathogens by recognising their specific molecular patterns. Cell membrane-associated TLR4 (recognises lipopolysaccharide (LPS) of Gram-negative bacteria) and endosomal TLR7/8 (recognise viral single-stranded RNA) are known to activate hypoxia inducible factor-1α (HIF-1α) protein (necessary for cellular adaptation to the inflammatory stress) via redox-dependent mechanism. TLR4 triggers the cross talk between HIF-1α and apoptosis signal-regulating kinase 1 (ASK1), whereas TLR7/8 activates HIF-1α in the ASK1-independent manner. Here, we report that in THP-1 and RAW264.7 macrophages, ligand-induced activation of the TLR4 but not TLR7/8 induces activation and transcriptional upregulation of sphingosine kinase 1 (SphK1) in extracellular signal-regulating kinase and phospholipase C-1γ/PI3 kinase-dependent manner. TLR4-mediated SphK1 activation was found to be critical for the redox-dependent activation of HIF-1α and ASK1, as well as for the prevention of LPS-induced activation of caspase 3 and the expression of pro-inflammatory cytokine interleukin-6.


Subject(s)
Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Inflammation Mediators/metabolism , Interleukin-6/biosynthesis , Lipopolysaccharides/pharmacology , MAP Kinase Kinase Kinase 5/metabolism , Phosphotransferases (Alcohol Group Acceptor)/metabolism , Toll-Like Receptor 4/metabolism , Animals , Calcium Signaling/drug effects , Caspase 3/metabolism , Enzyme Activation/drug effects , Humans , Intracellular Space/drug effects , Intracellular Space/metabolism , Mice , Models, Biological
3.
Mol Immunol ; 45(11): 3045-9, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18462799

ABSTRACT

Sepsis is the leading cause of death in intensive care units, which reflects detrimental host response to infection where lipopolysaccharide (LPS) shared by Gram-negative bacteria acts as a potent activator of immune cells via Toll-like receptor 4 (TLR4). Recently it was found that TLR4 downstream signalling leads to the accumulation of hypoxia-inducible factor 1 alpha (HIF-1alpha), which is important for TLR4-dependent expression of pro-inflammatory cytokines, however, basic biochemical mechanisms of involvement of this protein in TLR4 downstream signalling remains unclear. Here we found that knockdown of the expression of HIF-1alpha protein by siRNA led to the depletion of ATP, which corresponded to the constant increase in the activity of apoptosis signal-regulating kinase 1 (ASK1) and therefore apoptosis as estimated based on the increase in the activity of caspase 3. On the other hand, LPS-dependent production of IL-6 was attenuated. Treatment of HIF-1alpha knockdown cells with extracellular ATP in combination with LPS preserved the IL-6 expression but not the activity of ASK1 on the level observed in LPS-stimulated control cells. We therefore suggested that HIF-1alpha protein supports LPS-dependent expression of IL-6 by preventing depletion of ATP. On the other hand HIF-1alpha protein is selectively required for down-regulation of ASK1 activated during LPS-induced TLR4 downstream signalling.


Subject(s)
Adenosine Triphosphate/deficiency , Apoptosis/drug effects , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Interleukin-6/biosynthesis , Lipopolysaccharides/pharmacology , Myeloid Cells/cytology , Myeloid Cells/metabolism , Toll-Like Receptor 4/immunology , Cell Line, Tumor , Cobalt/pharmacology , Down-Regulation/drug effects , Extracellular Space/drug effects , Humans , MAP Kinase Kinase Kinase 5/genetics , Myeloid Cells/drug effects , Myeloid Cells/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...